Astrocyte polarization in glaucoma: a new opportunity

Area of Science:

• Neuroscience
• Ophthalmology
• Cell Biology

Background:

• Astrocyte polarization categorizes astrocytes into A1 (neurotoxic) and A2 (neuroprotective) phenotypes.
• While studied in neurodegeneration, trauma, and infections, astrocyte polarization's role in glaucoma remains underexplored.

Purpose of the Study:

• To review astrocyte astrogliosis characteristics in glaucoma.
• To explore the concept of astrocyte polarization in glaucoma pathogenesis.
• To propose novel hypotheses regarding astrocyte polarization in glaucoma.

Main Methods:

• Review of existing literature on astrocyte polarization and glaucoma.
• Analysis of astrocyte changes in glaucoma, including morphological, molecular, proliferative, and functional aspects.
• Synthesis of findings from other diseases to infer mechanisms in glaucoma.

Main Results:

• A1 astrocytes contribute to retinal ganglion cell death in glaucoma.
• A1 astrocyte neurotoxins selectively target damaged retinal ganglion cells.
• Reactive astrocytes in the optic nerve head may represent A2 astrocytes, crucial for prognosis.

Conclusions:

• A1 astrocyte neurotoxins may involve the complement system's membrane-attacking complex.
• Therapeutic strategies targeting astrocyte polarization (reducing A1, increasing A2) show promise for glaucoma.
• Glucagon-like peptide-1 receptor agonists demonstrate potential by reducing A1 astrocytes in ocular hypertension models.